International Pharmaceutical Regulatory Monitor
November 2012
| Vol.
40 No.
11
Canada Expects Minimal Industry Burden from New API GMP Regs
Proposed good manufacturing practice (GMP) regulations will cost active pharmaceutical ingredient makers in Canada nearly $1 million dollars in initial costs and $100,000 in annual compliance, according to an analysis by Health Canada.
This article is viewable by subscribers only. To view this article, please select an option below.
|